Loading...
Docoh

Karuna Therapeutics (KRTX)

Employees
Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
Karuna Therapeutics, Inc. (the “Company”) held its previously announced Annual Meeting of Stockholders (the “Annual Meeting”) on June 16, 2021, at which a quorum was present. As of April 19, 2021, the record date for the Annual Meeting, there were 29,457,896 shares of the Company’s common stock outstanding and entitled to vote at the Annual Meeting. The Company’s stockholders voted on the following matters, which are described in detail in the Company’s Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on April 27, 2021: (i) to elect Christopher Coughlin, James Healy, M.D., Ph.D. and Jeffrey Jonas, M.D. as Class II directors of the Company, each to serve for a three-year term expiring at the Company’s annual meeting of stockholders in 2024 or until his successor has been duly elected and qualified (“Proposal 1”) and (ii) to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 (“Proposal 2”).
Proposal 1 – Election of Directors
The Company’s stockholders approved the Class II director nominees recommended for election in Proposal 1 at the Annual Meeting. The Company’s stockholders voted for the Class II directors as follows:

NameVotes ForVotes WithheldBroker Non-Votes
Christopher Coughlin22,074,4004,986,606854,618
James Healy, M.D., Ph.D.16,593,89110,467,115854,618
Jeffrey Jonas, M.D.19,444,2057,616,801854,618
Proposal 2 – Ratification of the Selection of Independent Registered Public Accounting Firm
The Company’s stockholders ratified the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021. The votes cast at the Annual Meeting were as follows:

Votes ForVotes AgainstAbstain
27,913,1894232,012
No other matters were submitted to or voted on by the Company’s stockholders at the Annual Meeting.